IRINOTECAN ALPHAPHARM irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act
Product name
IRINOTECAN ALPHAPHARM irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial
Sponsor
ARTG
148579
Date of effect
Decision type
Cancelled under Section 30(1)(c) of the Act